Skip to search formSkip to main contentSkip to account menu

TCV 116

Known as: TCV-116 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

candesartan cilexetil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Product development and programmatic implementation of TYPBAR TCV® and ROTAVAC® vaccines
TYPBAR TCV® is a result of dedicated product development at Bharat Biotech since 2001, with the strains provided by Dr. John… 
2005
2005
Angiotensin II and Calcium Blockers Prevent Glomerular Phenotypic Changes in Remnant Kidney Model 1
Recent studies on various models of glomerular diseases Indicate that glomerular injury is associated with the phenotypic… 
1998
1998
Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
To elucidate the contribution of the renin-angiontensin system (RAS) to glomerular injury in salt-sensitive hypertension, we… 
1998
1998
Cardiovascular effects of chronic treatment with the AT1 receptor antagonist, TCV-116, in adult spontaneously hypertensive rats
1997
1997
Nitric oxide synthase I immunoreactivity in the macula densa of the kidney is angiotensin II dependent.
The present study was undertaken to clarify the mechanism of the regulation of nitric oxide synthase (NOS)-I in the macula densa… 
1997
1997
Cardiovascular effects of chronic hypertensive treatment with the AT1 receptor antagonist, TCV-116, in adult spontaneously hypertensive rats
1996
1996
Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model
Background Despite the current progress in immunosuppressive regimens, the incidence of graft coronary artery disease (CAD) after… 
1996
1996
Efficacy and safety of candesartan cilexetil (TCV-116) on essential hypertension in combination therapy with calcium antagonists
1996
1996
Hypotensive effect and safety of TCV-116 (candesartan cilexetil), a new angiotensin II receptor antagonist, combination therapy with thiazides on essential hypertension-clinical late phase II study-
1996
1996
Chronic administration of angiotensin II receptor antagonist, TCV－116, in cardiomyopathic hamsters
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)